Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Bollywood Actress Gurleen Chopra Is the New Face of Protein Brand GC ISOPURE Business
  • Based On the Constitutional Rights of Every Indian, Nagpur Witnessed the Muhurt of Upcoming Film ’26 November’ Entertainment
  • An E-commerce Revolution is Underway at Zimson Watches Lifestyle
  • Poornima University, Jaipur to offer 100 percent scholarship to 11 girls of Rajasthan Royals Foundation Press Release
  • ‘Pahechaan Awards’ Season – 3 was hosted to boost the confidence of the business community Post Covid-19 Business
  • Stylebee Fashion – Miss & Mrs. Face of Asia Pageant Finalist Debasruti Saha Lifestyle
  • Lifelong Learner With A Passion For Sustainable Fashion: Meet Driving Force Behind Innovation In India Business
  • Record Breaking WV Connect: 700+ wedding fraternities across the globe unite to create 101 Destination Weddings at Asia’s Largest B2B Wedding Summit Business

Weinnovate Biosolutions Gets Featured In List of Top 10 Biotech Companies 2021

Posted on September 27, 2021 By

September 27: Weinnovate Biosolutions Private Limited (WIBPL) gets featured in the top 10 biotech companies in 2021 list with pioneer Indian biotechnology institutes like the Serum Institute and Biocon. The Pune, Maharashtra-based company, WIBPL, has been listed in the prestigious top 10 biotech companies in 2021 list for developing antimicrobial solutions that reduce incidences of Hospital Acquired Infections (HAI).

The ISO-certified Startup company, WIBPL, has been founded by Dr. Milind Choudhari CEO, Dr. Anupama S. Engineer, and Dr. Prasad Bhagat in 2016. The sole purpose of the company is to serve quality and affordable infection prevention & control healthcare solutions. “We develop quality and affordable biotechnology solutions without compromise”, says Dr. Milind Choudhari, Founder and CEO of WIBPL. They are a dedicated team of technologists and scientists that aim to provide efficient, rapid, affordable, and advanced healthcare solutions.

Hospital Acquired Infections (HAI) are those infections that people usually catch while they are hospitalized. Hospital Acquired Infections (HAI) is one of the leading causes of morbidity and mortality across the globe. To prevent the spread of HAIs, the need for effective infection prevention policies and control procedures is quintessential. The spread of HAIs is a huge cost for both the hospital as well as the patient. While they increase a patient’s length of stay in the hospital as well as finances. In the case of the hospitals, they lead to longer bed occupancy and reduces the number of patients they could serve instead. Some common types of HAIs are bloodstream infections, surgical site infections, urinary tract infections, ventilator-associated – pneumonia, and other nosocomial infections.

The hospital management, physician, nursing staff, central sterilization service, food service, laundry service, housekeeping, and infection control team play a huge role in preventing the spread of HAIs. Every individual and healthcare service provider is equally responsible for the prevention of HAIs. However, the absence of trained health workers, incompetent surveillance, limited staff training, less focus on prevention activities, non-operational national and regional prevention programs are some of the biggest loopholes in existing prevention solutions.

HAIs are spreading like wildfire despite the implementation of existing prevention solutions. Realizing the need of the hour several biotechnology companies have come up with new and innovative biotechnology solutions. One such incredible solution is the WIBPL’s unique, patented, and next-generation antimicrobial device, ‘SilvoGuard’ Antimicrobial Medical device. The SilvoGuard medical devices prevent the spread of HAIs by preventing bacterial adhesion and biofilm formation on the surfaces of medical devices. The main objective is to ensure zero infections occur during the stay of a patient in the hospital.

SilvoGuard Antimicrobial Medical devices are based upon the next-gen NanoAgCide™ technology. The technology is a colloidal and antimicrobial silver nanoparticle solution that has been clinically tested for being highly effective. From making the product services non-toxic to antimicrobial for lifetime use, WIBPL’s products like SilvoGuard Antimicrobial Foley Catheter prevent the spread of infections and reduce intake of antibiotics to control it. Thus, money saved by using SilvoGuard overweighs the amount spent otherwise on antibiotic treatments, diagnostic tests, etc. in case infection occurs.

Medical devices are responsible for a large portion of nosocomial infections, particularly in critically ill patients. Device-associated infections can cause major medical and economic sequelae. Amongst HAI, 80% of cases of urinary tract infection are catheter-related. Catheter is one of the fast running medical consumables used for all bed-ridden patients for assisting urination. Catheter-Associated Urinary Tract Infections (CA-UTI) results in prolonged hospital stay by almost 17 days and adds to increased hospital bill. The average rate of occupancy of bed for any hospital is also detrimentally affected by CAUTI. With such background, it is of utmost importance to use an antimicrobial catheter that will prevent the incidences of UTI. WIBPL has designed SilvoGuard Antimicrobial Foley catheter, which is made 100% antimicrobial using its patented silver nanoparticle technology. SilvoGuard Antimicrobial Foley Catheters have clinically proven to inhibit the occurrence of UTI. SilvoGuard catheters are environmentally friendly and does not contain any toxic chemicals. Currently, CAUTI is addressed by administering empirical, broad-spectrum antibiotics to the patients who are catheterized. Such empirical antibiotic treatment can lead to the rise of antimicrobial resistance and multi-drug resistant pathogens.

In only a few months duration, the SilvoGuard Antimicrobial catheters have been used across hospitals all over India. More than 10,000 patients have been catheterized with SilvoGuard Catheters and have been successfully saved from the risk of developing CA-UTI. WIBPL aims to touch more than 50,000 lives in 2021-22. The catheters have been thoroughly tested by several third parties, and studies have been published highlighting the efficiency of the SilvoGuard catheters. Several more peer-reviewed publications are on the way for SilvoGuard. Sharing the vision with WIBPL to make India AtmaNirbhar by using Make-In-India healthcare products, the company has been backed by one of India’s top Venture Capitalists, Chiratae Ventures. With this financial muscle backing, the company aims to grow massively in years to come.

Check out the top10 list at:

https://www.theindustryoutlook.com/manufacturing/ranking/top-10-biotechnology-companies-2021-rid-164.html

Learn More about them at http://www.weinnovatebiosolutions.com/

https://www.silvoguard.com

 

Business Tags:Business

Post navigation

Previous Post: Alankit Ltd. Shortlisted as National Business Correspondent for Punjab National Bank (PNB)
Next Post: India Fashion Awards Season Two A Fashionable Soiree

Related Posts

  • A decade of direct mutual funds: Investors amass 1000s of crores of extra returns by saving on commissions, says ET Money Business
  • Process9 – Market Leader in AI-Enabled Localization Technology, Plans to Broaden Its Global Reach Business
  • Lipsa Swain from Odisha becomes Mrs. India Queen of Hearts Pageant Winner 2022 Business
  • Celekt launches ‘Mission E-waste’ Business
  • ADDSHOP E-RETAIL Giving Boost To Make In India Initiative And Contributing Their Bit Towards Generating Employment Business
  • The Visionary Leadership Propelling ALC Group’s Rapid Ascent To Excellence Business

Recent Posts

  • Astro Parduman Honored with National Creator Award 2025 for Excellence in Astrology, Numerology & Occult Sciences
  • Manappuram Presents Unique Times MBA Award to Vijay Sankeshwar in Historic 19th Edition
  • Guardians of Public Assets: How Honest IAS Officers Like Hari Chandana Protect Government Properties
  • India Unveils ‘Raktsetu’, Its First-Ever Blood Donation App, During Historic Drive Led by Astro Parduman
  • India UK FTA Deal: 7 Strategic Gains and the Crosswinds Facing PM Modi’s Trade Vision

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Music of Punjabi film Nanak Naam Jahaaz Hai released Today Entertainment
  • Sandhya Shetty Celebrates her Birthday with the success of her OTT Debut “Dharavi Bank” and Malayalam Debut “Corona Papers” Business
  • Witness the Start-Up Carnival 4.0 by Techno India Group, The largest start-up fest in East India Business
  • Chaitali Das Conferred Honorary Doctorate by NIILM University for Skill Development Education
  • Vietnamese Film ‘A Fragile Flower’ Shines with Housefull Premiere at 55th IFFI Goa 2024 Entertainment
  • Sea Breeze Group Announces “La Wisteria” 80 boutique Luxe Apartments with Private Pools in Siolim, North Goa Business
  • Get Ready, ‘Lamborghini’ ft. Rohan Mehra and Riya Sharma Drops Exclusively on Desi Tadka Music Entertainment
  • Tree AMS Unveils Revolutionary Franchise Management Technology, Transforming Business Operations and Excellence Across Industries Business

Copyright © 2025 Daily News India.

Powered by PressBook News WordPress theme